Placebo for Aliskiren

DRUG3 trials

Sponsors

Novartis, Novartis Pharmaceuticals

Conditions

Cardiovascular EventsHeart FailureHypertension

Phase 2

A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction Between Aliskiren and Furosemide in Patients With Heart Failure

CompletedNCT01125514

Novartis PharmaceuticalsHeart Failure

Start: 2010-05-31End: 2011-08-31Updated: 2012-09-10

Phase 3

A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People

TerminatedNCT01259297

Novartis PharmaceuticalsCardiovascular Events

Start: 2011-01-31End: 2012-11-30Updated: 2014-04-08

Phase 4

Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus

CompletedNCT00927394

NovartisHypertension

Start: 2009-05-31End: 2011-10-31Updated: 2012-12-06

Related Papers

Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: the APOLLO trial

European Heart Journal2014-03-0925 citations

Hypertension: is it more than just a numbers game?

The Journal of Physiology2013-11-29